← back to search

Róbert Hermann

Oslo University Hospital · NO
🔎 Find collaborators in Genetics · Statistical and Nonlinear Physics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Genetics · Statistical and Nonlinear Physics
Research interest
Research interests include Diabetes and associated disorders, Nonlinear Waves and Solitons, Advanced Topics in Algebra, and Pancreatic function and diabetes.
h-index
64
citations
20,812
works
523
NIH funding
primary concept
Medicine
email

Recent publications

Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre-Menopausal Women With Relapsing Multiple Sclerosis.
2025cited by 0position: contributordoi
Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials.
2023cited by 4position: contributordoi
Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions.
2022cited by 9position: contributordoi
Experimental helium‐beam radiography with a high‐energy beam: Water‐equivalent thickness calibration and first image‐quality results
Medical Physics 2022cited by 7position: middledoi
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine.
2021cited by 5position: contributordoi
Mechanistic Considerations About an Unexpected Ramipril Drug-Drug Interaction in the Development of a Triple Fixed-Dose Combination Product Containing Ramipril, Amlodipine, and Atorvastatin.
2021cited by 0position: contributordoi
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
The Lancet Oncology 2020cited by 880position: middledoi
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
The Lancet Oncology 2019cited by 379position: middledoi
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis.
2019cited by 52position: contributordoi
Effects of cladribine tablets on heart rate, atrio-ventricular conduction and cardiac repolarization in patients with relapsing multiple sclerosis.
2019cited by 4position: contributordoi
Drug-Drug Interactions: Progress Over the Past Decade and Looking Ahead to the Future.
2019cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2019–2025)Margareta Metzner · German Cancer Research Center1 papers (2022–2022)Christian Schömers · University Hospital Heidelberg1 papers (2022–2022)Tim Gehrke · German Cancer Research Center1 papers (2022–2022)C. Knobloch · German Cancer Research Center1 papers (2022–2022)Stefan Scheloske · University Hospital Heidelberg1 papers (2022–2022) · 1 papers (2022–2022)M. Martišíková · German Cancer Research Center1 papers (2022–2022)D. Jack · Merck Serono (Italy)1 papers (2025–2025)Axel Nolting · Merck KGaA, Darmstadt (Germany)1 papers (2025–2025)Jennifer Q. Dong · Ono Pharmaceutical (United States)1 papers (2025–2025)Karthik Venkatakrishnan · Merck KGaA, Darmstadt (Germany)1 papers (2025–2025)Kerstin Hellwig · Christian Doppler Klinik1 papers (2025–2025)Axel Krebs‐Brown · University of Warwick1 papers (2025–2025)Sumedh Gaikwad · Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals1 papers (2025–2025)Stephan Brons · Heidelberg University1 papers (2022–2022)Amin Rostami‐Hodjegan · Predictive Science (United States)1 papers (2019–2019)F. Kehrein · German Cancer Research Center1 papers (2022–2022)Oliver Jäkel · German Cancer Research Center1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Genetics · Statistical and Nonlinear Physics →